USA |NASDAQ |USD
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.
|Public Float||25.64M||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||4.32%||Ex-Dividend Date|
|Held by Institutions||18.85%||IPO Date||Sep 18, 2020|
|Dec 20||Dec 19||Dec 18|
|Sep 21||Jun 21||Mar 21|
Last quarter (ended on September 30 ,2021) Compass pathways generated a net income of $-15.85M, representing a 5.33% increase compared to the same quarter a year before (ended on September 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Compass pathways generated a net income of $-60.33M, representing a 207.64% increase compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Compass pathways's “Financials” Section
For the last quarterly earnings period (ended on September 30, 2021) CMPS reported $-0.38 EPS for the quarter, beating the average analysts’ forecasts of $-0.47 EPS by $0.09 (19.93%).
View More Details on Compass pathways's 'Earnings' Section
Compass pathways trades on the NASDAQ stock market in USA under the ticker symbol "CMPS". Compass pathways’s stock symbol can also be displayed as "NASDAQ:CMPS".
Compass pathways (NASDAQ:CMPS) is owned by 18.84% institutional shareholders and by 4.32% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "Avidity Partners Management LP", "Logos Global Management LP" and "Victory Capital Management Inc.", representing 6.35% of Compass pathways’s total shares outstanding.
Explore More Details on Compass pathways's “Ownership” Section
Compass pathways's key executive team includes the following managers:
Compass pathways (NASDAQ:CMPS) is classified under the "Healthcare" sector and under the "Medical Care Facilities" industry.
Currently the number of employees working for Compass pathways is 61.
Compass pathways (NASDAQ:CMPS) is headquartered in United Kingdom.
Compass pathways’s mailing address is 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT.
The company’s phone number is 44 64 6905 3974.